#1 Clinical Trials Search in Europe

Tiotropium Bromide

This article examines the use of Tiotropium Bromide in clinical trials for various respiratory conditions. Tiotropium Bromide is a medication that has been studied for its potential benefits in treating chronic obstructive pulmonary disease (COPD), asthma, and other breathing disorders. The trials discussed here explore different formulations, dosages, and patient populations to assess the drug’s efficacy and safety profile.

Table of Contents

What is Tiotropium Bromide?

Tiotropium Bromide is a medication primarily used to treat respiratory conditions. It belongs to a class of drugs called anticholinergics, which work by relaxing and opening up the airways in the lungs[1]. This medication is also known by its brand names, which include Spiriva[2].

Conditions Treated

Tiotropium Bromide is used to treat several respiratory conditions, including:

  • Chronic Obstructive Pulmonary Disease (COPD): This is a group of lung diseases that cause airflow blockage and breathing-related problems[1].
  • Asthma: A condition in which a person’s airways become inflamed, narrow and swell, and may produce extra mucus, making it difficult to breathe[3].

How It Works

Tiotropium Bromide works as a bronchodilator, which means it helps to open up the airways in your lungs. It does this by blocking certain nerve signals that cause the airways to constrict. By keeping the airways open, it makes breathing easier for people with conditions like COPD and asthma[1].

Administration Methods

Tiotropium Bromide is typically administered through inhalation. There are several devices used to deliver the medication:

  • Respimat Inhaler: A device that turns the medication into a fine mist for inhalation[3].
  • HandiHaler: A device where capsules containing the medication are placed and then inhaled[4].
  • Easyhaler: Another type of inhaler device used to deliver tiotropium[5].

Efficacy and Benefits

Research has shown that Tiotropium Bromide can provide several benefits for patients with respiratory conditions:

  • Improved lung function: It can increase the amount of air a person can forcefully exhale in one second (FEV1)[1].
  • Reduced exacerbations: It may help decrease the frequency of sudden worsening of symptoms in COPD patients[6].
  • Better asthma control: In patients with asthma, it can help improve symptoms and lung function[3].
  • Improved quality of life: By helping patients breathe more easily, it can enhance overall quality of life[7].

Dosage and Usage

The typical dosage of Tiotropium Bromide varies depending on the condition being treated and the delivery device used. For example:

  • For COPD: Often prescribed as 18 micrograms once daily via HandiHaler[4].
  • For asthma in adolescents: Doses may range from 1.25 to 5 micrograms once daily via Respimat inhaler[8].

It’s important to note that the exact dosage should always be determined by your healthcare provider based on your individual condition and response to the medication.

Side Effects and Safety

Like all medications, Tiotropium Bromide can cause side effects, although not everyone experiences them. Common side effects may include:

  • Dry mouth
  • Sinus infection
  • Sore throat
  • Cough

Serious side effects are rare but can include allergic reactions or worsening of breathing problems. Always inform your doctor of any side effects you experience[2].

Ongoing Research

Researchers continue to study Tiotropium Bromide to better understand its effects and potential uses. Some areas of ongoing research include:

  • Its use in children and adolescents with asthma[3].
  • Comparing different delivery devices to determine which is most effective[9].
  • Investigating its effects when combined with other medications[7].

As research continues, our understanding of how to best use Tiotropium Bromide to help patients with respiratory conditions will continue to improve.

Aspect Details
Conditions Studied COPD, Asthma, Spinal Cord Injury
Age Groups Children (6-11 years), Adolescents (12-17 years), Adults
Dosage Forms Inhalation solution, Inhalation powder, Capsules
Delivery Devices Respimat inhaler, Easyhaler, HandiHaler
Dosage Ranges 1.25 mcg to 18 mcg
Primary Outcomes FEV1, FVC, PEF, Pharmacokinetic parameters (Cmax, AUC)
Secondary Outcomes Asthma control, Rescue medication use, Quality of life measures
Study Designs Randomized, Double-blind, Placebo-controlled, Crossover trials
Treatment Duration Single dose to 4 weeks
Comparators Placebo, Different formulations of Tiotropium Bromide

FAQ

  • What is Tiotropium Bromide used for? Tiotropium Bromide is primarily used to treat chronic obstructive pulmonary disease (COPD) and asthma. It helps to improve breathing by relaxing and opening the airways in the lungs.
  • How is Tiotropium Bromide administered? Tiotropium Bromide is typically administered through inhalation devices such as the Respimat inhaler, Easyhaler, or HandiHaler. The specific device and dosage may vary depending on the condition being treated and the individual patient's needs.
  • What are the common dosages of Tiotropium Bromide used in clinical trials? Clinical trials have explored various dosages, including 1.25 mcg, 2.5 mcg, 5 mcg, 10 mcg, and 18 mcg. The appropriate dosage depends on factors such as the patient's age, condition severity, and the specific formulation being used.
  • Are there any side effects associated with Tiotropium Bromide? While specific side effects were not detailed in the provided trial information, as with any medication, there may be potential side effects. It's important for patients to discuss possible side effects with their healthcare provider before starting treatment.
  • How long do the effects of Tiotropium Bromide last? Tiotropium Bromide is typically administered once daily, suggesting that its effects last for about 24 hours. Some trials measured outcomes up to 72 hours after dosing to assess the drug's duration of action.

Ongoing Clinical Trials on Tiotropium Bromide

  • Study Comparing Trelegy with LABA-LAMA Drug Combination for Improving COPD Control in High-Risk Patients

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Tiotropium Bromide: A long-acting anticholinergic medication used to treat chronic obstructive pulmonary disease (COPD) and asthma by relaxing and opening the airways in the lungs.
  • Chronic Obstructive Pulmonary Disease (COPD): A group of lung diseases, including chronic bronchitis and emphysema, that cause airflow blockage and breathing-related problems.
  • Asthma: A chronic lung condition characterized by inflammation and narrowing of the airways, leading to breathing difficulties, wheezing, and coughing.
  • Forced Expiratory Volume (FEV1): The amount of air a person can forcefully exhale in one second, used as a measure of lung function.
  • Peak Expiratory Flow (PEF): The maximum rate of airflow achieved during a forced exhalation, used to assess lung function and airway obstruction.
  • Spirometry: A common lung function test that measures how much air a person can breathe in and out, and how quickly they can exhale.
  • Bronchodilator: A medication that relaxes and widens the airways in the lungs, making it easier to breathe.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the effects of the drug being studied.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body over time.
  • Respimat Inhaler: A type of inhaler device used to deliver medication in a fine mist form for inhalation into the lungs.

References

  1. https://clinicaltrials.gov/study/NCT00568503
  2. https://clinicaltrials.gov/study/NCT02172495
  3. https://clinicaltrials.gov/study/NCT01383499
  4. https://clinicaltrials.gov/study/NCT03400241
  5. https://clinicaltrials.gov/study/NCT05246046
  6. https://clinicaltrials.gov/study/NCT02586649
  7. https://clinicaltrials.gov/study/NCT01465906
  8. https://clinicaltrials.gov/study/NCT01122680
  9. https://clinicaltrials.gov/study/NCT04850144